NLS Pharmaceutics Amends Merger Agreement with Kadimastem
Ticker: NCEL · Form: 6-K · Filed: May 5, 2025 · CIK: 1783036
| Field | Detail |
|---|---|
| Company | Nls Pharmaceutics LTD. (NCEL) |
| Form Type | 6-K |
| Filed Date | May 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: merger, amendment, legal-agreement
TL;DR
NLS Pharma just tweaked its merger deal with Kadimastem AGAIN. Third amendment filed May 5, 2025.
AI Summary
On May 5, 2025, NLS Pharmaceutics Ltd. entered into a third amendment to its Merger Agreement with Kadimastem Ltd. and NLS Pharmaceutics (Israel) Ltd. This amendment modifies the terms of the original agreement, which was first established on November 4, 2024, and previously amended on January 30 and February 17, 2025.
Why It Matters
This filing indicates ongoing adjustments to a significant merger, which could impact the future structure and operations of NLS Pharmaceutics and Kadimastem.
Risk Assessment
Risk Level: medium — Amendments to merger agreements can signal complexities or renegotiations that may affect the deal's completion or terms.
Key Players & Entities
- NLS Pharmaceutics Ltd. (company) — Filer and party to the merger agreement
- Kadimastem Ltd. (company) — Party to the merger agreement
- NLS Pharmaceutics (Israel) Ltd. (company) — Party to the merger agreement
- May 5, 2025 (date) — Date of the Third Amendment
- November 4, 2024 (date) — Original Merger Agreement date
FAQ
What is the primary purpose of the Third Amendment to the Merger Agreement?
The filing states that the Third Amendment modifies the terms of the Agreement and Plan of Merger between NLS Pharmaceutics Ltd., Kadimastem Ltd., and NLS Pharmaceutics (Israel) Ltd.
When was the original Merger Agreement entered into?
The original Agreement and Plan of Merger was entered into on November 4, 2024.
What were the previous amendment dates for the Merger Agreement?
The Merger Agreement was previously amended on January 30, 2025, and on February 17, 2025.
Which entities are parties to the Merger Agreement?
The parties to the Merger Agreement are NLS Pharmaceutics Ltd., Kadimastem Ltd., and NLS Pharmaceutics (Israel) Ltd.
What is the filing date of this Form 6-K?
This Form 6-K was filed on May 5, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 5, 2025 regarding NLS Pharmaceutics Ltd. (NCEL).